Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06079918 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania

Study acronym: MMS-MAP
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor 2 versions Re-verified since Jun 27, 2025, no change to tracked fieldsv7-v8
  2. Notable Trial status: Not Yet Recruiting to Recruitingv6 Show 4 more changesShow less
    • Primary completion date: Jun 2026 to Mar 2027
    • Study sites: 0 to 1
    • Study completion date: Sep 2026 to Jun 2027
    • Start date changed from estimate of Mar 2025 to Mar 3, 2025
  3. Notable Primary completion date: Jun 2025 to Jun 2026v5 Show 4 more changesShow less
    • Start date: Dec 2024 to Mar 2025
    • Study completion date: Sep 2025 to Sep 2026
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints revised (31)
  4. Notable Start date: Sep 2024 to Dec 2024v4
  5. Notable Start date: Feb 2024 to Sep 2024v3
  6. Notable Start date: Nov 2023 to Feb 2024
    • Eligibility criteria expanded, about 12 words
    • Secondary endpoints: 28 to 31
    v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an individually randomized controlled trial to assess the effect of multiple micronutrient supplements (MMS) containing 60 and 45 mg iron as compared to MMS containing 30 mg of iron (standard UNIMMAP formulation) on maternal moderate or severe anemia. This study will help inform countries like Tanzania that currently use IFA containing 60 mg of iron regarding the dose of iron to use in MMS.
Trial Details
NCT Number NCT06079918
Lead Sponsor George Washington University
Collaborators: Ifakara Health Institute, Harvard School of Public Health (HSPH), Muhimbili University of Health and Allied Sciences, Africa Academy for Public Health, Columbia University
Conditions
(from sponsor)
Pregnancy Related
Related terms Anemia
Enrollment 6,381 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov